Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 275, Issue 4 44-4, 1998, Pages

  Pelleymounter, Mary Ann ^a,b   Cullen, Mary Jane ^a   Healy, Denis ^a   Hecht, Randy ^a   Winters, Dwight ^a   McCaleb, Michael ^a  

^a AMGEN INC   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Appetite; Half maximal effective dose; Obese or lean CD 1 mice; Pair feeding

Indexed keywords

CORTICOSTERONE; KETONE; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FOOD INTAKE; LIPID METABOLISM; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0031768588     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1998.275.4.r950     Document Type: Article

References (32)

1. Ahima, R., D. Prabakaran, C. Mantzoros, D. Qu, B. Lowell, E. Maratos-Flier, and J. Flier. Role of leptin in the neuroendocrine response to fasting. Nature 382: 250-252, 1996.
2. Bray, G., and D. York. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59: 719-806, 1979.
3. Campfield, L., F. Smith, Y. Guisez, R. Devos, and P. Burn. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546-549, 1995.
4. Considine, R., E. Considine, C. Williams, M. Nyce, S. Magosin, T. Bauer, E. Rosato, J. Colberg, and J. Caro. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J. Clin. Invest. 95: 2986-2988, 1995.
5. Considine, R., M. Sinha, M. Heiman, A. Kriauciunas, T. Stephans, M. Nyce, J. Ohannesian, C. Marco, L. McKee, T. Bauer, and J. Caro. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292-295, 1996.
6. Cumin, F., H.-P. Baum, M. de Gasparo, and N. Levens. Removal of endogenous leptin from the circulation by the kidney. Int. J. Obes. 21: 495-504, 1997.
7. Dagogo-Jack, S., C. Fanelli, D. Paramore, J. Brothers, and M. Landt. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 45: 695-698, 1996.
8. Frederich, R., A. Hamann, S. Anderson, B. Lollmann, B. Lowell, and J. Flier. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1: 1311-1314, 1995.
9. Ghilardi, N., S. Ziegler, A. Wiestner, R. Stoffel, M. Heim, and R. Skoda. Defective STAT signalling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. USA 93: 6231-6235, 1996.
10. Halaas, J., C. Boozer, J. Blair-West, N. Fidahusein, D. Denton, and J. Friedman. Physiological response to long term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. USA 94: 8878-8883, 1997.
11. Halaas, J., K. Gajiwala, M. Maffei, S. Cohen, B. Chait, K. Rabinowitz, R. Lallone, S. Burley, and J. Friedman. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269: 543-546, 1995.
12. Hamilton, B., D. Paglia, A. Kwan, and M. Deitel. Increased obese mRNA expression in omental fat cells from massively obese humans. Nat. Med. 1: 953-956, 1995.
13. Heiman, M., R. Ahima, L. Craft, B. Schoner, T. Stephans, and J. Flier. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138: 3859-3863, 1997.
14. Klein, S., S. Coppack, V. Mohamed-Ali, and M. Landt. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45: 984-987, 1996.
15. Lau, D., S. Mallard, G. Wariner, A. Watson, E. Cheung, and J. Young. Pharmacokinetics of recombinant human leptin in mice. Obesity Res. 4, Suppl. 1: 38S, 1996.
16. Lee, G.-H., R. Proenca, J. Montez, K. Carroll, J. Darvishzadeh, J. Lee, and J. Friedman. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635, 1996.
17. Leshner, A., V. Litwin, and R. Squibb. A simple method for carcass analysis. Brain Res. 9: 281-282, 1972.
18. Levin, N., C. Nelson, A. Gurney, R. Vandlen, and F. De Sauvage. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc. Natl. Acad. Sci. USA 93: 1726-1730, 1996.
19. Lonnqvist, F., P. Arner, L. Nordfors, and M. Schalling. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med. 1: 950-952, 1995.
20. Maffei, M., J. Halaas, E. Ravussin, R. Pratley, G. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, P. Kern, and J. Friedman. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1: 1155-1161, 1995.
21. Maffei, M., M. Stoffel, M. Barone, B. Moon, M. Dammerman, E. Ravussin, C. Bogardus, D. Ludwig, J. Flier, M. Talley, S. Auerback, and J. Friedman. Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 45: 679-682, 1996.
22. Mercer, J., N. Hoggard, L. Williams, C. Lawrence, L. Hannah, and P. Trayhurn. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387: 113-116, 1996.
23. Montague, C., I. Farooqi, J. Whitehead, M. Soos, H. Rau, N. Warehams, C. Sewter, J. Digby, S. Mohammed, J. Hurst, C. Cheetham, A. Barley, A. Barnett, J. Prins, and S. O'Rahilly. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387: 903-908, 1997.
24. Pelleymounter, M., M. Cullen, M. Baker, R. Hecht, D. Winters, T. Boone, and F. Collins. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543, 1995.
25. Rosenbaum, M., M. Nicolson, J. Hirsch, S. Heymsfield, D. Gallagher, F. Chu, and R. Leibel. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J. Clin. Endocrinol. Metab. 81: 3424-3427, 1996.
26. Segal, K., M. Landt, and S. Klein. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 45: 988-991, 1996.
27. Shimabukuro, M., K. Koyama, G. Chen, M.-Y. Wang, F. Trie, Y. Lee, C. Newgard, and R. Unger. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. USA 94: 4637-4641, 1997.
28. Stephans, T., M. Basinski, P. Bristow, J. Bue-Valleskey, S. Burgett, L. Craft, J. Hale, J. Hoffman, H. Hsiung, A. Kriauciunas, W. MacKellar, P. Rosteck, B. Schoner, D. Smith, F. Tinsley, X.-Y. Zhang, and M. Heiman. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530-532, 1995.
29. Tartaglia, L., M. Dembski, X. Weng, N. Deng, J. Culpepper, R. Devos, G. Richards, L. Campfield, F. Clark, J. Deeds, C. Muir, S. Sanker, A. Moriarty, K. Moore, J. Smutko, G. Mays, E. Woolf, C. Monroe, and R. Tepper. Identification and expression cloning of a leptin receptor, OB-R. Cell 83: 1263-1271, 1995.
30. Van Heek, M., D. Compton, C. France, R. Tedesco, A. Fawzi, M. Graziano, E. Sybertz, C. Strader, and H. Davis. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 99: 385-390, 1997.
31. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. Friedman. Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-431, 1994.
32. Zhou, Y.-T., M. Shimabukuro, K. Koyama, Y. Lee, M.-Y. Wang, F. Trie, C. Newgard, and R. Unger. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc. Natl. Acad. Sci. USA 94: 6386-6390, 1997.